In The News
Second law firm investigating class action against Coles, Woolworths
Bunnings’ facial recognition tech found to have breached privacy laws
Marsh fights ‘serious’ finding it used Greensill litigation docs in UK case
CBA class action judge used ‘far too onerous’ test, appeals court told
Fletcher can’t pry into judge’s background as law firm class action head
‘Out of licence and out of control’: Maxim seeks injunction against licensee
Court OKs stolen wages settlement, holds off on ‘eye-watering’ fees
ASIC takes NAB to court over customer hardship claims
Seven settles lawsuit by ex-Spotlight reporter
Class action over ‘cookie cutter’ legal advice says declassing application should wait
Please login to bookmarkClose

Australian drug maker Juno Pharmaceuticals has hit back at claims it is infringing the patent for US-based Pfizer’s post-operative pain killer Dynastat, saying the patent is invalid.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au